Howard N N - OmicsDI

Show results for

Unknown (8783)
Transcriptomics (151)
Proteomics (79)
Genomics (37)
Models (5)
Metabolomics (5)
Genomic (2)
Multiomics (1)

Organisms

Homo sapiens (130)
Mus musculus (55)
Rattus norvegicus (15)
Saccharomyces cerevisiae (10)
Drosophila melanogaster (7)
Arabidopsis thaliana (6)
Legionella pneumophila subsp. pneumophila str. Philadelphia 1 (3)
Legionella pneumophila (3)
Bos taurus (3)
Escherichia coli (2)
Phytophthora infestans (2)
Macaca mulatta (2)
synthetic construct (2)
Rattus rattus (2)
Mycobacterium tuberculosis (2)
Escherichia coli K-12 (1)
Xenopus laevis (1)
cellular organisms (1)
Methanosarcina acetivorans (1)
Colletotrichum higginsianum (1)
Pseudomonas putida F1 (1)
Vitis sp. cv. 'Norton' (1)
Drosophila (1)
Spodoptera frugiperda (1)
Yersinia pseudotuberculosis (1)
Toxoplasma gondii (1)
Bos indicus (1)
Yersinia enterocolitica (1)
Staphylococcus aureus (1)
Glycine max (1)

Organisms

human vaginal metagenome (2)
Homo sapiens (2)

Repository

biostudies-arrayexpress (166)
pride (73)
EGA (17)
BioModels (5)
MetaboLights (5)
ENA (5)
MassIVE (4)
dbGaP (2)
PanoramaPublic (2)

Tissue

Cell culture (12)
Liver (10)
Brain (6)
Hepatocyte (5)
Kidney (5)
Embryonic stem cell (4)
Heart (4)
Blood plasma (3)
Fibroblast (3)
Macrophage (3)
Permanent cell line cell (3)
Blood (2)
Cardiac muscle tissue of ventricle (2)
Early embryonic cell (2)
Epithelial cell (2)
Lung (2)
Skin (2)
Antler (1)
B cell (1)
Beige adipocyte (1)
Blood serum (1)
Brown adipocyte (1)
Brown adipose tissue (1)
Embryonic fibroblast (1)
HEK-293T cell (1)
HeLa cell (1)
Leaf (1)
Macrophage cell line (1)
Mammary gland (1)
T cell (1)

Disease

Cardiovascular system disease (5)
Leukemia (2)
Primary tumor (1)
Normal (1)
Acute leukemia (1)
Biliary atresia (1)
Breast cancer (1)
Influenza (1)
Malignant neoplasm of ovary (1)
Rhabdoid cancer (1)
Skin cancer (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (73)
Shotgun proteomics (42)
Bottom-up proteomics (15)
Affinity purification coupled with mass spectrometry proteomics (12)
Data-dependent acquisition (12)
Mass spectrometry (5)
SWATH MS (5)
Gel-based experiment (3)
SRM/MRM (3)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
Data-independent acquisition (2)
Illumina HiSeq 2000, unknown (1)
Top-down proteomics (1)

Instrument Platform

NextSeq 500 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Illumina HiSeq 4000 (2)
Q Exactive (2)
Lightwave (1)
Variable Atmosphere Incubator (1)
GenePix 4000B [Axon Instruments] (1)
Ion Torrent Proton (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
AB 5500xl Genetic Analyzer (1)
Orbitrap Fusion Lumos (1)
QE-HF (1)
Flow injection analysis MS - (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - hilic (1)
MS Imaging - (1)

Publication Date

2013 (27)
2015 (21)
2021 (20)
2010 (18)
2011 (15)
2008 (15)
2014 (14)
2020 (13)
2024 (12)
2012 (12)
2026 (11)
2018 (11)
2006 (11)
2025 (11)
2016 (9)
2009 (7)
2022 (6)
2007 (6)
2019 (5)
2005 (5)
2023 (4)
2017 (2)

UNIPROT ID/AC

P00573 (1)
P07659 (1)
P09560 (1)
P26696 (1)
P42212 (1)
Q05116 (1)
Q90W58 (1)

CHEBI ID

CHEBI:33699 (2)
CHEBI:25017 (2)
CHEBI:28300 (2)
CHEBI:29016 (2)
CHEBI:6650 (2)
CHEBI:78320 (2)
CHEBI:17535 (1)
CHEBI:33697 (1)
CHEBI:36080 (1)
CHEBI:55474 (1)
CHEBI:56080 (1)
CHEBI:61448 (1)
CHEBI:134428 (1)
CHEBI:14321 (1)
CHEBI:15345 (1)
CHEBI:15351 (1)
CHEBI:15422 (1)
CHEBI:15467 (1)
CHEBI:15531 (1)
CHEBI:155821 (1)
CHEBI:15611 (1)
CHEBI:15741 (1)
CHEBI:15843 (1)
CHEBI:15846 (1)
CHEBI:15891 (1)
CHEBI:15978 (1)
CHEBI:15996 (1)
CHEBI:16027 (1)
CHEBI:16108 (1)
CHEBI:16335 (1)

Metabolite Name

Aspartate (2)
Glutamate (2)
Lactate (2)
Leucine (2)
Malate (2)
Succinate (2)
1-methylguanosine (1)
2,3-Dihydroxybenzoic acid (1)
2-phosphoglycolate (1)
3-Methylxanthine (1)
ADP (1)
AMP (1)
ATP (1)
Acetoacetyl-CoA (1)
Acetyl-CoA (1)
Adenosine (1)
Alanine (1)
Arginine (1)
Aspartame (1)
CE 18:0 (1)
Cer 34:0;2O (1)
Cer 34:1;2O|Cer 18:1;2O/16:0 (1)
Cer 36:1;2O (1)
Cer 38:0;3O (1)
Cer 40:0;2O|Cer 18:0;2O/22:0 (1)
Cer 40:1;2O|Cer 18:1;2O/22:0 (1)
Cer 40:2;2O|Cer 18:1;2O/22:1 (1)
Cer 42:0;2O|Cer 18:0;2O/24:0 (1)
Cer 42:0;3O|Cer 18:0;2O/24:0;O (1)
Cer 42:1;2O|Cer 18:1;2O/24:0 (1)

First Public Date

2021 (2)
2025 (1)
2022 (1)
2020 (1)

Modelling Approach

Ordinary differential equation model (4)
Constraint-based model (1)

Lab affiliation

Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester, UK (7)
Executive Science Officer, BioFrontiers InstituteDistinguished ProfessorProfessor, Howard Hughes Medical Institute MOLECULAR CELLULAR AND DEVELOPMENTAL BIOLOGY CU DENVER SCHOOL OF MEDICINE (3)
Department of Molecular Biology, Princeton University (2)
Howard Hughes Medical Institute Beth Israel Deaconess Medical Center Harvard Medical School (2)
Laboratory of chemical biology and microbial pathogenesis, The Rockefeller University, New York, USA (2)
Stanford School of Medicine (2)
University of Texas at Austin Molecular Biosciences (2)
1) Department of Chemistry, Stanford University, Stanford, California, USA 2) Howard Hughes Medical Institute, Stanford, California, USA (1)
1.Department of Molecular Biology and Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA, 2.Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA, 3.Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. (1)
Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester (1)
Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester. (1)
Chair, Cancer Biology & Genetics Program, SKI; Chair, Geoffrey Beene Cancer Research Center; Investigator, Howard Hughes Medical Institute; (1)
Chief Scientific Officer, BioFrontiers Institute Distinguished Professor, Department of Molecular, Cellular, and Developmental Biology Professor, Howard Hughes Medical Institute (1)
Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia (1)
Clinical Diagnostic Laboratory Department of Clinical Veterinary Medicine Vetsuisse Faculty University of Bern Bern Switzerland (1)
Dana-Farber Cancer Institute Harvard Medical School Broad Institute Howard Hughes Medical Institute (1)
Dana-Farber Cancer Institute, Harvard Medical School, Howard Hughes Medical Institute (1)
David Geffen School of Medicine, UCLA, USA BD2K Center of Excellence for Big Data Computing at UCLA, UCLA, USA (1)
Department of Biochemistry, The University of Utah, Salt Lake City, UT, USA Howard Hughes Medical Institute, University of Utah, Salt Lake City, UT, USA (1)
Department of Biology, Massachusetts Institute of Technology, Building 68, 31 Ames St., Cambridge, MA 02139 Howard Hughes Medical Institute, Chevy Chase, MD (1)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Cell Biology, Harvard Medical School, Boston, MA, USA. Howard Hughes Medical Institute, Chevy Chase, MD, USA. (1)
Department of Cellular and Molecular Pharmamcology, UCSF (1)
Department of Chemistry, Stanford University Howard Hughes Medical Institute, Stanford University (1)
Department of Chemistry, Stanford University, Stanford, California, USA Howard Hughes Medical Institute, Stanford, California, USA (1)
Department of Genetics, Harvard Medical School, Boston, MA 021152 Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA0211 Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Howard Hughes Medical Institute, Boston, MA 02115 (1)
Department of Medicine, Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA (1)
Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA (1)
Department of Molecular Biology, Princeton University, New Jersey, USA (1)
Department of Neurological Sciences, University of Nebraska Medical Center, Omaha NE (1)
Department of Neuroscience, School of Medicine, University of Florida (1)

IsPrivate

False (5)

Submitter Keywords

Manuscript Accepted (1)

Modification

1x(15)N labeled L-leucine (1)

Study type

Transcription profiling by array (99)
RNA-seq of coding RNA (19)
ChIP-seq (13)
Unknown experiment type (8)
Methylation profiling by array (8)
Other (6)
Comparative genomic hybridization by array (3)
ChIP-chip by tiling array (2)
ATAC-seq (2)
Transcription profiling by SAGE (1)
Cell line - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
Genotyping by array (1)
DNA-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (642)
2021 (637)
2020 (579)
2015 (578)
2023 (553)
2014 (543)
2018 (527)
2019 (521)
2016 (497)
2017 (475)
2025 (467)
2024 (432)
2011 (395)
2013 (392)
2012 (377)
2010 (297)
2009 (268)
2008 (220)
2007 (107)
2006 (83)
2005 (68)
2026 (59)
2004 (47)
2003 (41)
2001 (32)
2002 (31)
2000 (25)
1999 (21)
1998 (17)
1997 (14)

Previous page
1 / 907
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 907
Next page

Sort by:

Relevance

Page size

Optimal Dissociation Methods Differ for N- and O-glycopeptides

Site-specific characterization of glycosylation requires intact glycopeptide analysis, and recent efforts have focused on how to best interrogate glycopeptides using tandem mass spectrometry (MS/MS). Beam-type collisional activation, i.e., higher-energy collisional dissociation (HCD), has been a val...

ORGANISM(S): Bos taurus (Bovine) Homo sapiens (Human)

2020-07-20 | PXD017646 | Pride

N-glycomics and glycoproteomics of LARGE1dTM

We performed N-glycomics and glycoproteomics on a LARGE1dTM protein recombinantly expressed in HEK cells.

ORGANISM(S): Homo sapiens (Human)

2025-08-21 | PXD060053 | Pride

Large1

Longidorus ferrisi n. sp. from California Citrus.

Not available

S-EPMC3365311 | biostudies-literature

A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.

Not available

S-EPMC10433989 | biostudies-literature

Ribosomal synthesis of N-methyl peptides.

Not available

S-EPMC2728122 | biostudies-literature

A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation.

Not available

S-EPMC7090375 | biostudies-literature

Designed oligomers of cyanovirin-N show enhanced HIV neutralization.

Not available

S-EPMC3161612 | biostudies-literature

Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis

Hepatic fibrosis is a wound-healing response to chronic liver injury, which may result in cirrhosis and liver failure. The c-Jun N-terminal kinase-1 (JNK1) gene has been shown to be involved in liver fibrosis. Here, we aimed to investigate the molecular mechanism and identify the cell-type involved ...

ORGANISM(S): Mus musculus

2013-11-27 | E-GEOD-40041 | biostudies-arrayexpress

CRISPR screens and lectin microarrays identify high mannose N-glycan regulators.

Not available

S-EPMC11574202 | biostudies-literature

miRNA expression profiles of erythroid cells following hydroxyurea treatment for sickle cell anemia

We hypothesized that miRNA regulation may be invloved in hydroxyurea-mediated fetal hemoglobin induction. Microarray analysis was utilized as an initial screening tool to determine differential miRNA expression in CD71+ erythroid cells comparing cells from control individuals without sickle cell ane...

ORGANISM(S): Homo sapiens

2011-11-21 | E-GEOD-32035 | biostudies-arrayexpress

Previous page
1 / 907
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 907
Next page

Sort by:

Relevance

Page size

9062 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Submitter Keywords

Modification

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets